Even three years post-infection, a subset of COVID survivors shows a persistently altered immune landscape, marked by elevated cytokines and incomplete recovery of key immune cell populations.🧵
Some inflammatory signals remain elevated, and certain immune cell populations never normalize. The strongest and most consistent changes involve the T-cell compartment rather than innate immune cells.
The authors describe the pattern as resembling immunosenescence because
naive CD4 and CD8 T cells - the reserve needed to respond to new infections - remain persistently reduced.
This is a hallmark of aging immune systems.
What this likely means biologically?
Reduced adaptive flexibility
Greater tendency toward chronic inflammatory activation
Less efficient immune reset after infection
At first glance - immune aging. Their immune profile resembles what we normally see in older individuals.
Early after infection, inflammation was driven mainly by monocytes.
However, by 2-3 years post-infection, those innate immune abnormalities largely normalized.
At that point, the persistent inflammatory state appears to be maintained primarily by T cells, especially Th17 subsets.
This represents a transition from an acute innate immune response to a chronic adaptive immune dysregulation.
Th17 cells normally play protective roles at epithelial barriers.
But when chronically activated, they are strongly associated with -
Persistent tissue inflammation
Autoimmune-like phenotypes
Ongoing immune activation even without active infection
In simple terms. Th17 responses are useful in acute defense, but harmful when they fail to shut off.
The most important finding.
The study identifies two functionally different Th17 subsets.
Pathogenic LTB+ Th17 cells
Strong pro-inflammatory gene expression, positive correlation with inflammatory cytokines, association with long-COVID symptoms such as pain, smell disturbances, and neuropsychiatric complaints
They may act as a biological bridge between persistent immune activation and clinical symptoms.
RORC+ Th17 cells - potentially regulatory
Negative correlation with inflammatory cytokines
Features suggesting a counter-inflammatory or compensatory role
They may represent an attempt by the immune system to restore balance.
The study finds long-term elevation of two important inflammatory mediators.
S100A8 (alarmin) - signals ongoing tissue stress or damage
IL-16 - attracts and activates CD4 T cells
These molecules likely create an environment that sustains pathogenic Th17 populations even years after infection.
The cohort size is moderate (47).
Measurements are from peripheral blood, not tissues.
Associations with symptoms are correlations
It involved the virus circulating at the very beginning of the pandemic, and the patients were hospitalized.
So the study essentially shows what long-term immunity looks like after the first pandemic wave.
But - the mechanisms described in the study
Th17-driven chronic inflammation
reduced naive T-cell reserves
persistent alarmin signals
are not specific to a particular variant, but rather appear to be linked to the severity and systemic intensity of the infection.
Sum:
COVID-19 can leave behind long-lasting immune remodeling, characterized by
Chronic low-grade inflammation
Persistent T-cell dysregulation
Reduced naive T-cell reserves
A sustained Th17-dominant inflammatory environment
This pattern resembles a state of premature immune aging combined with chronic immune activation.
Zheng at al., T cell-driven sustained inflammation and immune dysregulation mimicking immunosenescence for up to three years post-COVID-19. link.springer.com/article/10.100…
The immune pattern seen years after COVID has striking parallels with other conditions.
Premature immune aging (loss of naive T cells)
chronic viral infections like HIV/CMV (persistent activation)
autoimmune diseases driven by Th17 inflammation
It reflects long-term immune remodeling.
In essence, the immune system appears to shift from an acute response into a chronic dysregulated state.
This is best described as persistent immune dysregulation!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This pediatric long COVID study found an immune fingerprint where the authors explicitly flag parallels with chronic viral infections (they name HIV-1) not as a slogan, but as part of how they interpret their own data🧵
JCI Insight 2026. Pediatric long COVID vs kids post-infection without long COVID, sampled around ~3 months after acute infection.
We covered this topic in the preprint, now we’re going into more detail given how important it is.
What they did - deep immune phenotyping (PBMC flow cytometry) + antibody profiling (anti-RBD/S2/N IgG/IgA) + pseudovirus neutralization.
After COVID and HIV (even on ART), your cells can carry a clear immune aging signature - especially inside naive CD8 T cells🧵
A new paper uses single-cell RNA-seq to ask a sharper question.
Is the aging signal coming from changed immune-cell proportions (systemic), or from aging-like shifts inside the cells themselves (intrinsic)?
The team built a T-cell aging clock called Tictock (T immune cell transcriptomic clock).
It predicts cell type + transcriptomic age across 6 T-cell subsets.
SARS-CoV-2 in brain tumors - what does it actually mean?
A new study analyzed brain tumor samples from 72 COVID-19 patients (Omicron BA.5 wave) to see whether the virus can be found directly inside tumors - and how it affects their immune environment🧵
First - nothing mystical here.
Tumors are still tissue. They often have abnormal vessels, disrupted barriers, and altered immunity.
So the real question isn’t can virus be there? - but what happens if it is.
Why might viral components be found in tumors at all?
Tumors have leaky, abnormal blood vessels and impaired drainage (EPR effect), and brain tumors often disrupt the blood-brain barrier.
This allows viruses, proteins, and immune complexes circulating in blood to more easily enter and persist within tumor tissue.
This new study shows that SARS-CoV-2 can systematically reprogram cellular metabolism to support its own survival.
This isn’t just tissue damage.
It’s a redirection of the body’s energy systems🧵
This is a recent mini-review examining how COVID-19 affects lipid profiles and the metabolome, especially in people with type 2 diabetes.
By synthesizing multiple studies, the authors show that SARS-CoV-2 profoundly disrupts metabolic balance.
One consistent finding after infection?
Decreases in HDL, LDL, and total cholesterol,
variable changes in triglycerides
These shifts are not random.
They closely track with inflammation and disease severity.
Researchers looked at markers of cellular and mitochondrial damage in the blood of people with Long COVID and linked them to cognition, psychological distress, and inflammation. They identified several surprising associations🧵
Finding 1. Long COVID = lower relative ccf-mtDNA
At first glance, this is surprising.
People usually expect - mitochondrial damage - more mtDNA released into blood.
But here, researchers found lower relative levels.
But this does not necessarily mean less damage.
It likely reflects dysregulation of mitochondrial quality control (mitophagy).
One of the most important recent studies on post-COVID biology delivers a concerning message.
SARS-CoV-2 doesn’t just affect immune cells.
It can leave long-lasting changes directly in the immune proteins circulating in our blood.🧵
Think of the immune system in three layers.
immune cells (T, B, NK…)
signaling molecules
effector proteins - antibodies and complement
This study shows persistent changes in the deepest layer - the effector proteins themselves.
Researchers analyzed blood samples from more than 400 people after COVID-19.
They identified hundreds of chemical alterations in proteins - called ncAA modifications.
It’s about proteins becoming chemically different.